Wang et al. discovered that the anticancer mechanism of Sacroflavonoside primarily involves the regulation of apoptosis and autophagy-related proteins, including Bax, Caspase-3, Beclin-1, LC3-II, ultimately leading to apoptosis and autophagic cell death in GC cells (Wang Q. et al., 2021). The gene discussed is BECN1; the disease is gastric cancer.